Oliver Lagore Vanvalin Investment Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-91
Closed -$19.2K – 756
2023
Q4
$19.2K Buy
91
+56
+160% +$11.9K 0.01% 321
2023
Q3
$7.02K Sell
35
-3
-8% -$596 ﹤0.01% 496
2023
Q2
$7.04K Buy
38
+6
+19% +$1.11K ﹤0.01% 527
2023
Q1
$6.13K Buy
+32
New +$5.79K ﹤0.01% 459

Other funds holding CME

Oliver Lagore Vanvalin Investment Group's CME Position: Q1 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of CME Group (CME) in Q1 2024, closing a stake of 91 shares — an estimated $19.2K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in CME in Q1 2023 and held it in 4 quarters. The position peaked at $19.2K in Q4 2023. 1,376 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 91 CME Group shares in Q1 2024, an estimated $19.2K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in CME Group in Q1 2023 and held it in 4 quarters.
  • Oliver Lagore Vanvalin Investment Group's CME Group position peaked at $19.2K in Q4 2023.
  • 1,376 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q1 2024, filed 15 May 2024.